1-8 of 8
Daniel Rauch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Efficacy of a 6-Month Regimen of Rituximab and Lenalidomide in Follicular Lymphoma Patients in Need of First Therapy: Updated Analysis of the SAKK 35/10 Randomized Trial

Emanuele Zucca, Saemi Schaer, Anna Vanazzi, Bjørn Østenstad, Ulrich Mey, Daniel Rauch, Björn E. Wahlin, Felicitas Hitz, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés José María Ferreri, Fatime Krasniqi, Michèle Voegeli, Urban Novak, Thilo Zander, Hanne Bersvendsen, Christoph Mamot, Walter Mingrone, Anastasios Stathis, Stefan Dirnhofer, Stefanie Hayoz, Eva Kimby
Journal: Blood
Blood (2023) 142 (Supplement 1): 295.
https://doi.org/10.1182/blood-2023-173957
Published: 2023
Journal Articles

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Clinical Trials & Observations
Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi, Bjørn Østenstad, Ulrich J. M. Mey, Daniel Rauch, Björn E. Wahlin, Felicitas Hitz, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés J. M. Ferreri, Andreas Lohri, Urban Novak, Thilo Zander, Hanne Bersvendsen, Mario Bargetzi, Walter Mingrone, Fatime Krasniqi, Stefan Dirnhofer, Stefanie Hayoz, Hanne Hawle, Simona Berardi Vilei, Michele Ghielmini, Eva Kimby
Journal: Blood
Blood (2019) 134 (4): 353–362.
https://doi.org/10.1182/blood-2018-10-879643
Published: 2019
Includes: Supplemental data
Journal Articles

Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research)

Rudolf A. Benz, MD, Kornelius Arn, MD, Martin Andres, Thomas Pabst, MD PhD, Urban Novak, Felicitas Hitz, MD, Reinhard Zenhäusern, Yves Chalandon, MD PhD, Ulrich Mey, MD, Sabine Blum, Daniel Rauch, Willy Nettekoven, Nathan Cantoni, MD, Mario Bargetzi, MD, Alix O'Meara, MD, Andreas Lohri, MD, Simona Berardi, PhD BSc, Qiyu Li, Georg Stussi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2875.
https://doi.org/10.1182/blood-2018-99-114301
Published: 2018
Journal Articles

Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03

Christian Taverna, MD, Giovanni Martinelli, MD, Felicitas Hitz, MD, Walter Mingrone, MD, Thomas Pabst, MD PhD, Lidija Cevreska, MD PhD, Auro del Giglio, MD, Anna Vanazzi, MD, Daniele Laszlo, MD, Johann Raats, Daniel Rauch, Daniel Vorobiof, Andreas Lohri, MD, Emanuele Zucca, Celine Rueegsegger, Stephanie - Rondeau, Corinne Rusterholz, Michele Ghielmini
Journal: Blood
Blood (2018) 132 (Supplement 1): 1601.
https://doi.org/10.1182/blood-2018-99-116864
Published: 2018
Journal Articles

Rituximab Plus Lenalidomide Versus Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. First Analysis of Survival Endpoints of the Randomized Phase-2 Trial SAKK 35/10

Eva Kimby, MD professor, Stephanie Rondeau, MSc, Anna Vanazzi, MD, Bjorn Ostenstad, MD PhD, Ulrich J.M. Mey, MD, Daniel Rauch, MD, Björn E Wahlin, MD PhD, Felicitas Hitz, MD, Micaela Hernberg, MD, Ann-Sofie Johansson, MD, Peter de Nully Brown, MD PhD, Hans Hagberg, MD PhD, Andres J.M. Ferreri, MD professor, Andreas Lohri, MD professor, Urban Novak, MD, Thilo Zander, MD, Hanne Bersvendsen, MD, Mario Bergetzi, MD, Walter Mingrone, MD, Fatime Krasniqi, MD PhD, Stefan Dirnhofer, MD professor, Hanne Hawle, MD, Simona Berardi, PhD, Michele Ghielmini, MD professor, Emanuele Zucca
Journal: Blood
Blood (2016) 128 (22): 1099.
https://doi.org/10.1182/blood.V128.22.1099.1099
Published: 2016
Journal Articles

Rituximab Plus Lenalidomide Improves the Complete Remission Rate in Comparison with Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. Primary Endpoint Analysis of the Randomized Phase-2 Trial SAKK 35/10

Eva Kimby, Giovanni Martinelli, Bjorn Ostenstad, Ulrich JM Mey, Daniel Rauch, Björn E Wahlin, MD PhD, Felicitas Hitz, MD, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés J.M. Ferreri, Andreas Lohri, Urban Novak, Thilo Zander, Hanne Bersvendsen, Mario Bargetzi, Walter Mingrone, Fatime Krasniqi, Stephan Dirnhofer, Hanne Hawle, MD, Simona Berardi, Steffi Demmel, Stephanie Rondeau, Emanuele Zucca, MD
Journal: Blood
Blood (2014) 124 (21): 799.
https://doi.org/10.1182/blood.V124.21.799.799
Published: 2014
Journal Articles

Rituximab Maintenance Treatment For a Maximum Of 5 Years In Follicular Lymphoma: Results Of The Randomized Phase III Trial SAKK 35/03

Christian J. Taverna, MD, Giovanni Martinelli, Felicitas Hitz, Walter Mingrone, Thomas Pabst, MD, Lidija Cevreska, Auro del Giglio, MD, Anna Vanazzi, Daniele Laszlo, Johann Raats, Daniel Rauch, Daniel A. Vorobiof, Andreas Lohri, MD, Emanuele Zucca, MD, Christine Biaggi Rudolf, Stephanie Rondeau, Corinne Rusterholz, Michele Ghielmini, MD
Journal: Blood
Blood (2013) 122 (21): 508.
https://doi.org/10.1182/blood.V122.21.508.508
Published: 2013
Journal Articles

Bioluminescence Imaging of Spontaneous Lymphomas and Contribution of Distinct NFκB Pathways.

Lee Ratner, MD, PhD, Leon Bernal-Mizrachi, MD, Daniel Rauch, PhD, John Harding, BA, Shimon Gross, PhD, David Piwnica-Worms, MD PhD
Journal: Blood
Blood (2006) 108 (11): 2377.
https://doi.org/10.1182/blood.V108.11.2377.2377
Published: 2006